Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma

Fig. 2

Survival curves for patients with Stage-III–IVA NPC. The OS curves showed there was no significant difference between the two groups (a). The DFS curves showed that the Weekly group was better than the Triweekly group (P = 0.025, there was a significant difference between the groups) (b). The DMFS (c) and LRFS (d) curves showed no significant differences between the two groups

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us